Press release
Postoperative Pain Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis
Postoperative Pain Pipeline Insight
Postoperative Pain Pipeline constitutes 45+ key companies continuously working towards developing 50+ Postoperative Pain treatment therapies, analyzes DelveInsight.
Postoperative Pain Overview:
Postoperative or postsurgical pain is defined as pain persisting for more than 3 to 6 months after surgery, differing in nature and location from any pre-surgical pain. It is often associated with neuropathic pain caused by surgical injury to major peripheral nerves. While any surgery can result in persistent postoperative pain (PPP), procedures like inguinal hernia repair and thoracic surgery, leg amputation, and coronary artery bypass surgery are at higher risk due to potential nerve damage. Surgical techniques that minimize nerve injury are critical to reducing this risk. Postoperative pain is categorized as acute (up to 7 days post-surgery) or chronic (lasting over 3 months), arising from cutaneous, deep somatic, or visceral structures.
"Postoperative Pain Pipeline Insight 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Postoperative Pain Therapeutics Market.
Request for a sample report @ https://www.delveinsight.com/report-store/postoperative-pain-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Key Takeaways from the Postoperative Pain Pipeline Report
*
DelveInsight's Postoperative Pain pipeline report depicts a robust space with 45+ active players working to develop 50+ pipeline therapies for Postoperative Pain treatment.
*
In August 2024, Mylan Specialty, LP announced that MR-107A-02 is being evaluated for its safety and efficacy in treating acute pain following herniorrhaphy.
*
In August 2024, Jiangsu HengRui Medicine Co., Ltd. disclosed an ongoing study to assess the safety and effectiveness of bupivacaine liposome injection for local infiltration analgesia in pediatric orthopedic surgeries under real-world conditions.
*
In June 2024, Johnson & Johnson Consumer Inc. announced a study aimed at determining the effectiveness of a fixed-dose combination of acetaminophen and naproxen sodium compared to a placebo in reducing pain over a 48-hour period through multiple doses.
*
In March 2024, Formosa Pharmaceuticals and AimMax Therapeutics received FDA approval for clobetasol propionate ophthalmic suspension 0.05% (APP13007) to treat postoperative inflammation and pain after ocular surgery.
*
Key Postoperative Pain companies such as Vivozon Pharmaceutical Inc., LipoCure, InSitu Biologics, and others are evaluating new drugs for Postoperative Pain to improve the treatment landscape.
*
Promising Postoperative Pain pipeline therapies in various stages of development include VVZ-149, LC-400, INSB-200, and others.
Postoperative Pain Pipeline Analysis
The report provides insights into:
*
The report provides detailed insights into the key companies that are developing therapies in the Postoperative Pain Market.
*
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Postoperative Pain treatment.
*
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Postoperative Pain market.
Download our free sample report @ https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Postoperative Pain Companies
There are approx. 45+ key companies which are developing the therapies for Postoperative Pain. The companies which have their Postoperative Pain drug candidates in the most advanced stage, i.e. phase III include, Vivozon Pharmaceutical Inc.
DelveInsight's report covers around 22+ products under different phases of clinical development like
*
Late stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I) along with the details of
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
Postoperative Pain pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*
Intravenous
*
Subcutaneous
*
Oral
*
Intramuscular
*
Tropical
Postoperative Pain Products have been categorized under various Molecule types such as
*
Monoclonal Antibody
*
Peptides
*
Polymer
*
Small molecule
*
Gene therapy
Download Sample Pages to Get an in-depth Assessment of the Emerging Postoperative Pain Therapies and Key Companies: Postoperative Pain Clinical Trials and advancements https://www.delveinsight.com/report-store/postoperative-pain-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Postoperative Pain Pipeline Therapeutic Assessment
- Postoperative Pain Assessment by Product Type
- Postoperative Pain By Stage
- Postoperative Pain Assessment by Route of Administration
- Postoperative Pain Assessment by Molecule Type
Download Postoperative Pain Sample report to know in detail about the Postoperative Pain treatment market @ Postoperative Pain Therapeutic Assessment https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Postoperative Pain Current Treatment Patterns
4. Postoperative Pain - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Postoperative Pain Late-Stage Products (Phase-III)
7. Postoperative Pain Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Postoperative Pain Discontinued Products
13. Postoperative Pain Product Profiles
14. Postoperative Pain Key Companies
15. Postoperative Pain Key Products
16. Dormant and Discontinued Products
17. Postoperative Pain Unmet Needs
18. Postoperative Pain Future Perspectives
19. Postoperative Pain Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Postoperative Pain Pipeline Reports Offerings: https://www.delveinsight.com/report-store/postoperative-pain-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=postoperative-pain-clinical-trials-companies-therapeutic-assessment-therapies-treatment-algorithm-and-pipeline-analysis]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Postoperative Pain Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis here
News-ID: 4078703 • Views: …
More Releases from ABNewswire
Appy Pie Automate Unveils HR Automation for BambooHR & Slack
Appy Pie Automate has launched new HR Automation Templates for BambooHR and Slack, helping teams streamline leave requests, approvals, and notifications without manual intervention. By integrating HR workflows with Slack communication and BambooHR record-keeping, organizations can accelerate approval cycles, maintain accurate records, and improve employee experience.
Appy Pie Automate, a leader in AI Workflow automation [https://www.appypieautomate.ai/], has introduced new HR Automation Templates designed specifically for organizations using BambooHR integrations [https://www.appypieautomate.ai/integrate/apps/bamboohr/integrations] and…
Oakland County DUI Lawyer Paul J. Tafelski Addresses First Offense DUI Concerns …
Bloomfield Hills, MI - Attorney Paul J. Tafelski of Michigan Defense Law (https://www.michigandefenselaw.com/blog/will-i-go-to-jail-for-my-first-dui-in-michigan/) released an update addressing growing concerns surrounding first-offense DUI cases in Oakland County and the increasing need for reliable legal guidance for individuals facing these charges. As an established Oakland County DUI lawyer, Tafelski is introducing detailed insights into local court procedures, potential penalties, and the broader impact of a first-time DUI arrest on residents throughout the…
New Jersey DUI Lawyer Rachel Kugel Clarifies When DUI Applies To Bicycles And Mo …
Jersey City, NJ - New Jersey DUI lawyer Rachel Kugel of The Kugel Law Firm (https://thekugellawfirm.com/can-you-get-a-dui-on-a-bike-in-new-jersey/) released practical guidance on when impairment laws apply to cyclists and riders of motorized bicycles in New Jersey, addressing the recurring question: Can a person get a DUI on a bike?
As a New Jersey DUI lawyer, Kugel explains that state DUI statutes apply to the operation of a motor vehicle. A manually operated bicycle…
HVAC Contractor in Woodburn OR - Whirlwind Heating & Cooling Addresses Spike in …
Whirlwind Heating & Cooling is reporting a sharp increase in furnace breakdowns as Oregon faces a colder-than-usual winter season. Homeowners throughout Woodburn are experiencing heating system failures ranging from ignition malfunctions to complete unit shutdowns. The company has expanded availability to help residents restore heat quickly and keep homes safe during extended low temperatures.
Woodburn, OR - With temperatures dipping earlier and more sharply than usual across the Willamette Valley, homeowners…
More Releases for Postoperative
Postoperative Acute Pain Market Trends, Treatments, and Global Forecast
Postoperative acute pain (POAP) remains one of the most significant challenges in clinical care, affecting nearly 80% of patients after surgery. Poorly managed pain can lead to complications such as delayed recovery, prolonged hospital stays, readmissions, and higher healthcare costs. Traditionally, opioid analgesics have been the cornerstone of treatment, but rising concerns around opioid dependency and adverse effects are fueling demand for safer, multimodal pain management approaches.
Download Full PDF Sample…
Postoperative Pain Therapeutics Market Innovations and Trends for 2032
The Postoperative Pain Therapeutics market has become an essential sector within the healthcare industry, particularly in the wake of increasing surgical procedures and the subsequent need for effective pain management solutions. This market encompasses a wide range of therapeutics designed to alleviate pain following surgical interventions, ensuring patient comfort and satisfaction during recovery. With a focus on improving patient outcomes, the postoperative pain therapeutics market has seen significant advancements, driven…
Postoperative Pain Therapeutics Market Analysis and Forecast (2024-2032)
The introduction serves as the foundational section of our analysis. It aims to provide a comprehensive overview of the Postoperative Pain Therapeutics Market, emphasizing its significance and the purpose of the analysis.
The Postoperative Pain Therapeutics Market plays a pivotal role in the healthcare industry. It addresses the critical need for effective pain management following surgical procedures, contributing to patient comfort and recovery. This market has witnessed substantial growth due to…
Postoperative Pain Therapeutics Market: An In-Depth Analysis
In the ever-evolving landscape of healthcare, the Postoperative Pain Therapeutics Market has emerged as a significant player. This market, valued at USD 0.88 billion in 2023, is driven by various factors such as the production and commercialization of new drugs, increased research and development activities, rising health concerns, enhanced diagnostics facilities, and a growing global population. With a projected compound annual growth rate (CAGR) of 9.3% between 2024 and 2032,…
Postoperative Nausea and Vomiting Management Market Rising focus on patient comf …
Global Postoperative Nausea and Vomiting Management Market Overview:
The Postoperative Nausea and Vomiting Management market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Postoperative Nausea and Vomiting Management market has experienced significant growth, driven by factors such as increasing consumer demand,…
Prevention and management of postoperative endophthalmitis
The decisive criterion of postoperative endophthalmitis after cataract operations or intravitreal injections is the contamination of the operating area and the instruments / implants with pathogens during the surgical procedure. In traditional operating theaters, the "sterility" is very limited and only given directly under the supply air ceiling. However, the surgical field is almost completely shielded from the ultra-clean air by the surgical microscope and the surgeon's head, so that…
